Akers Biosciences Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,526.80
3,127.20
9,311.90
3,303.50
7,366.30
10,849
Depreciation, Depletion & Amortization
354.40
349.40
300.00
286.20
249.90
234.50
Other Funds
-
745.00
-
-
-
1,255.70
Funds from Operations
1,455.30
2,057.60
5,986.60
4,042.40
4,388.70
9,202.30
Changes in Working Capital
1,274.70
1,826.40
854.30
130.70
691.70
684.90
Net Operating Cash Flow
2,730.00
3,883.90
5,132.30
4,173.10
5,080.40
8,517.40
Capital Expenditures
123.10
25.00
113.00
123.30
54.50
Sale of Fixed Assets & Businesses
100.00
-
-
-
-
Purchase/Sale of Investments
-
9,266.60
5,185.50
3,967.10
4,960.20
Net Investing Cash Flow
68.20
9,286.90
5,078.50
3,843.80
5,014.70
Cash Dividends Paid - Total
-
15.80
-
-
-
Issuance/Reduction of Debt, Net
307.50
307.50
-
-
-
Net Financing Cash Flow
2,132.50
13,523.10
-
-
10,460.80
Net Change in Cash
529.40
352.20
53.80
329.40
365.70
Free Cash Flow
2,853.10
3,908.90
5,245.30
4,296.50
5,134.90
Other Sources
91.30
4.70
6.00
-
-
Change in Capital Stock
1,825.00
13,101.30
-
-
10,460.80
About Akers Biosciences
View Profile
